Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 9, 2022
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancerLuca Visani, Lorenzo Livi, Ivica Ratosa, et al.
Clinical and Translational Radiation Oncology|March 22, 2024
Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: Acute toxicity resultsIvica Ratosa, Angel Montero, Raquel Ciervide, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 18, 2026
Short-term quality of life after metastases-directed SBRT: Results of the ESTRO & EORTC OligoCare cohortDaniela Greto, Van Hemelrijck Mieke, Felix Oppong, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohortLuca Visani, Ivica Ratosa, Rupert Bartsch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 14, 2025
Repositioning Radiation Oncology at the centre of integrated oncology care: A manifesto of the European Society for Radiotherapy and Oncology (ESTRO)Icro Meattini, Marianne C Aznar, Luca Boldrini, et al.
The Lancet. Oncology|January 1, 2022
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancerIcro Meattini, Carlotta Becherini, Liesbeth Boersma, et al.
Breast (Edinburgh, Scotland)|May 8, 2023
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Sarah M Maritan, Andrea Quaiattini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2024
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohortFilippo Alongi, Luca Nicosia, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2024
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare studySebastian M Christ, Filippo Alongi, Umberto Ricardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 29, 2025
ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTROAlice Zamagni, Angel Montero Luis, Ingvil Mjaaland, et al.
Pageof 3